| scholarly article | Q13442814 |
| P2093 | author name string | Peter S Amenta | |
| Hirokazu Fukui | |||
| Tadayuki Oshima | |||
| Hiroto Miwa | |||
| Kiron M Das | |||
| Nancy Chen | |||
| Jiro Watari | |||
| Toshihiko Tomita | |||
| Kheng-Jim Lim | |||
| P2860 | cites work | Assessment of atrophic gastritis using the OLGA system | Q46605089 |
| Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia | Q46717354 | ||
| Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer event. | Q46891979 | ||
| The use of routine special stains for upper gastrointestinal biopsies | Q46990883 | ||
| Meta-analysis of the relationship between cagA seropositivity and gastric cancer | Q47264372 | ||
| Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer | Q48019587 | ||
| Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. | Q50498913 | ||
| Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. | Q50623833 | ||
| The significance of lymphoid follicles in the interpretation of gastric biopsy specimens. | Q50771565 | ||
| Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. | Q50917787 | ||
| Staging gastritis: an international proposal. | Q53264197 | ||
| High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. | Q53349508 | ||
| K-ras mutation in helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. | Q53392861 | ||
| Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. | Q53399548 | ||
| Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development. | Q53424085 | ||
| Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. | Q54265509 | ||
| Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? | Q54337028 | ||
| Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. | Q54601002 | ||
| Long-term follow-up of gastric histology after Helicobacter pylori eradication | Q56945822 | ||
| Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening | Q57569869 | ||
| Long-Term Follow-Up of 1,000 Patients Cured of Helicobacter pylori Infection Following an Episode of Peptic Ulcer Bleeding | Q59509406 | ||
| Helicobacter pylori cagA and vacA Genotypes as Predictors of Progression of Gastric Preneoplastic Lesions: A Long-Term Follow-Up in a High-Risk Area in Spain | Q60651512 | ||
| Gastric cancer occurrence in preneoplastic lesions: A long-term follow-up in a high-risk area in Spain | Q60651515 | ||
| Gastritis OLGA-staging & gastric cancer risk: a twelve year clinico-pathological follow-up study | Q61884190 | ||
| The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody | Q68155589 | ||
| Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks | Q68617138 | ||
| Sulphomucin-secreting intestinal metaplasia in the human gastric mucosa. An association with intestinal-type gastric carcinoma | Q68888529 | ||
| Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma | Q69646328 | ||
| Gastric intestinal metaplasia type III cases are classified as low-grade dysplasia on the basis of morphometry | Q70560864 | ||
| Prolonged achlorhydria and gastric neoplasia: is there a causal relationship? | Q70681144 | ||
| Adherence of Helicobacter pylori | Q71322552 | ||
| Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults | Q72295008 | ||
| Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia | Q72388090 | ||
| Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer | Q73605684 | ||
| Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? | Q73674241 | ||
| Clinical impact of routine biopsies of the gastric antrum and body | Q73853786 | ||
| Absence of BAT-26 instability in gastric intestinal metaplasia | Q74083340 | ||
| Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice | Q74250578 | ||
| Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer | Q75306492 | ||
| Histological risk markers for non-cardia early gastric cancer. Pattern of mucin expression and gastric cancer | Q79290961 | ||
| Epidemiology of Helicobacter pylori infection | Q80152035 | ||
| Clinicopathologic implications of genetic instability in intestinal-type gastric cancer and intestinal metaplasia as a precancerous lesion: proof of field cancerization in the stomach | Q80880094 | ||
| Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice | Q80945792 | ||
| Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae | Q81362522 | ||
| Preferential expression of cyclooxygenase-2 in colonic-phenotype of gastric intestinal metaplasia: association with helicobacter pylori and gastric carcinoma | Q82180275 | ||
| The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori | Q82586852 | ||
| Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up | Q82642782 | ||
| Evidence-based therapy according to the guideline for gastric ulcers is cost-effective in Japan | Q83400584 | ||
| The association of dupA and Helicobacter pylori-related gastroduodenal diseases | Q84110447 | ||
| Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication | Q84701146 | ||
| Epidemiology of peptic ulcer disease: endoscopic results of the systematic investigation of gastrointestinal disease in China | Q84800554 | ||
| Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients | Q24246267 | ||
| Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH | Q28305331 | ||
| Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma | Q29615026 | ||
| Helicobacter pylori infection and the development of gastric cancer | Q29615341 | ||
| The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification | Q29618627 | ||
| Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial | Q33378199 | ||
| Horizontal versus familial transmission of Helicobacter pylori | Q33379079 | ||
| The Helicobacter pylori duodenal ulcer promoting gene, dupA in China | Q33379280 | ||
| Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients | Q33380490 | ||
| Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? | Q33484552 | ||
| Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets | Q33643333 | ||
| Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies | Q33670744 | ||
| Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study. | Q33709984 | ||
| African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths | Q33756876 | ||
| Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma | Q33838334 | ||
| Cdx1 promotes differentiation in a rat intestinal epithelial cell line. | Q33882050 | ||
| Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India | Q33994171 | ||
| Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial | Q34013156 | ||
| Isolation and sequencing of a novel tropomyosin isoform preferentially associated with colon cancer | Q34137567 | ||
| Attempt to fulfil Koch's postulates for pyloric Campylobacter. | Q34197846 | ||
| Helicobacter pylori and gastric carcinogenesis. | Q34311677 | ||
| The prevalence of Helicobacter pylori infection in different countries. | Q34370026 | ||
| An intestine-specific homeobox gene regulates proliferation and differentiation | Q34370444 | ||
| Transmission and epidemiology of Helicobacter pylori. | Q34381727 | ||
| Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up | Q34395562 | ||
| Long term follow up of patients treated for Helicobacter pylori infection. | Q34619683 | ||
| H. pylori and gastric cancer: the Asian enigma | Q34640948 | ||
| American College of Gastroenterology guideline on the management of Helicobacter pylori infection | Q34645482 | ||
| Helicobacter pylori infection in young patients with gastric carcinoma | Q34734792 | ||
| Review article: intestinal metaplasia and gastric carcinogenesis | Q34764688 | ||
| Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan | Q35349737 | ||
| Gastric intestinal metaplasia: subtypes and natural history | Q35399651 | ||
| Microsatellite instability in gastric cancer and pre-cancerous lesions | Q35435893 | ||
| Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma | Q35595701 | ||
| Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication | Q35596845 | ||
| Focus on gastric cancer. | Q35681321 | ||
| Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer | Q35745452 | ||
| Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation | Q35760383 | ||
| Biomarkers predicting development of metachronous gastric cancer after endoscopic resection: an analysis of molecular pathology of Helicobacter pylori eradication | Q35785760 | ||
| Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis | Q35872061 | ||
| Gastritis staging in clinical practice: the OLGA staging system | Q35929516 | ||
| Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence | Q36018522 | ||
| Staging and grading of chronic gastritis | Q36080581 | ||
| The gastric precancerous cascade | Q36115055 | ||
| Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands | Q36172846 | ||
| Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique | Q36243482 | ||
| Helicobacter pylori in Iran: A systematic review on the association of genotypes and gastroduodenal diseases | Q36479958 | ||
| Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data | Q36487459 | ||
| Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis | Q36620949 | ||
| The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection | Q36714493 | ||
| Helicobacter pylori and gastric lymphonodular hyperplasia in children | Q36729209 | ||
| Purification of recombinant Helicobacter pylori urease apoenzyme encoded by ureA and ureB | Q36947079 | ||
| The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis | Q36996616 | ||
| Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review | Q37427454 | ||
| Helicobacter pylori: evidence-based review with a focus on immigrant populations | Q37595765 | ||
| Epidemiology of Helicobacter pylori infection in Malaysia--observations in a multiracial Asian population. | Q37763041 | ||
| Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis | Q37833878 | ||
| Eradication of Helicobacter pylori for prevention of ulcer recurrence after simple closure of perforated peptic ulcer: a meta-analysis of randomized controlled trials | Q38060332 | ||
| Helicobacter pylori infection in functional dyspepsia | Q38077448 | ||
| Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies. | Q38097128 | ||
| Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up | Q38133945 | ||
| Diagnosis and epidemiology of Helicobacter pylori infection | Q38134864 | ||
| Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease | Q38486265 | ||
| Mechanism of H. pylori intracellular entry: an in vitro study | Q39291680 | ||
| Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 | Q39605655 | ||
| Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. | Q39664365 | ||
| Novel risk markers for gastric cancer screening: Present status and future prospects | Q39800607 | ||
| The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer | Q39803338 | ||
| The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae. | Q39912026 | ||
| Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan | Q40013873 | ||
| Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer | Q40633333 | ||
| KRAS mutations predict progression of preneoplastic gastric lesions. | Q40822287 | ||
| Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. | Q40830476 | ||
| Review article: is Helicobacter pylori transmitted by the gastro-oral route? | Q41125398 | ||
| K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer | Q41384958 | ||
| Functional dyspepsia today. | Q41865426 | ||
| Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria | Q42519625 | ||
| Serum pepsinogens as a screening test of extensive chronic gastritis. | Q42523163 | ||
| Gene methylation in non-neoplastic mucosa of gastric cancer: age or Helicobacter pylori related? | Q42792399 | ||
| Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease | Q43296117 | ||
| Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication | Q43581382 | ||
| Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study | Q43700278 | ||
| Vacuolating toxin production in clinical isolates of Helicobacter pylori with different vacA genotypes | Q43742740 | ||
| Helicobacter pylori and nonmalignant diseases | Q43772737 | ||
| Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer | Q43788249 | ||
| Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori | Q44016286 | ||
| A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. | Q44113930 | ||
| Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study | Q44516440 | ||
| Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial | Q44727161 | ||
| Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated | Q45076105 | ||
| Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels | Q45222191 | ||
| Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands | Q46081388 | ||
| The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease | Q46447272 | ||
| Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease | Q46456021 | ||
| Isolation of Helicobacter pylori from human faeces | Q46534980 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Helicobacter pylori | Q180556 |
| Helicobacter pylori infectious disease | Q4497153 | ||
| chronic gastritis | Q16958168 | ||
| P304 | page(s) | 5461-5473 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development | |
| P478 | volume | 20 |
| Q95855857 | A Systematic Review of the Mechanisms Underlying Treatment of Gastric Precancerous Lesions by Traditional Chinese Medicine |
| Q92921617 | Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice |
| Q40821476 | Aggravation of Helicobacter pylori stomach infections in stressed military recruits |
| Q36993030 | An Observational Study on Aberrant Methylation of Runx3 With the Prognosis in Chronic Atrophic Gastritis Patients |
| Q49658071 | Analysis of 12 variants in the development of gastric and colorectal cancers |
| Q38870083 | Association between Helicobacter pylori infection and angiographically demonstrated coronary artery disease: A meta-analysis |
| Q90609119 | Association between interleukin-21 gene rs907715 polymorphism and gastric precancerous lesions in a Chinese population |
| Q36224232 | Association of Endoscopic Features of Gastric Mucosa with Helicobacter pylori Infection in Chinese Patients. |
| Q46243673 | Bacteriome and mycobiome associations in oral tongue cancer |
| Q40401463 | Binary mixture of Satureja hortensis and Origanum vulgare subsp. hirtum essential oils: in vivo therapeutic efficiency against Helicobacter pylori infection |
| Q92889745 | Blue laser magnifying endoscopy in the diagnosis of chronic gastritis |
| Q47647286 | Chronic diseases, inflammation, and spices: how are they linked? |
| Q92999511 | Clinical Significance of Lysophosphatidic Acid Receptor-2 (LPA2) and Krüppel-Like Factor 5 (KLF5) Protein Expression Detected by Tissue Microarray in Gastric Adenocarcinoma |
| Q40967062 | Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study |
| Q54245487 | Correlation between serum vitamin B12 level and peripheral neuropathy in atrophic gastritis. |
| Q90465648 | Correlation of xeroderma pigmentosum complementation group F expression with gastric cancer and prognosis |
| Q92081574 | Efficacy of traditional Chinese medicine for chronic gastritis: A meta-analysis of randomized controlled trials |
| Q91940153 | Esophagogastroduodenoscopy Findings in Patients on the Waiting List for Bariatric Surgery |
| Q33416507 | From prednisone to pylori: a case of Helicobacter pylori-induced chronic immune thrombocytopenia |
| Q55074295 | Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening. |
| Q92203807 | Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis |
| Q33786557 | Helicobacter pylori infection: old and new |
| Q26775839 | Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis |
| Q48299862 | Histopathology Findings in Patients Undergoing Laparoscopic Sleeve Gastrectomy |
| Q64243638 | In Vitro Activity of 3-Bromopyruvate, an Anticancer Compound, Against Antibiotic-Susceptible and Antibiotic-Resistant Strains |
| Q34521029 | Influence of inhomogeneous static magnetic field-exposure on patients with erosive gastritis: a randomized, self- and placebo-controlled, double-blind, single centre, pilot study |
| Q47595365 | Male non-insulin users with type 2 diabetes mellitus are predisposed to gastric corpus-predominant inflammation after H. pylori infection |
| Q61446086 | NKX6.3 protects against gastric mucosal atrophy by downregulating β-amyloid production |
| Q39662266 | Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families |
| Q91741830 | Phosphorylated STAT3 expression linked to SOCS3 methylation is associated with proliferative ability of gastric mucosa in patients with early gastric cancer |
| Q91699182 | Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk |
| Q38712652 | Prevalence and dynamics of Helicobacter pylori infection during childhood |
| Q90233808 | Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin |
| Q64107120 | Preventive Effect of CQPC08 on 4-Nitroquineline-1-Oxide Induced Tongue Cancer in C57BL/6 Mice |
| Q58568790 | Preventive Effect of Raw Liubao Tea Polyphenols on Mouse Gastric Injuries Induced by HCl/Ethanol via Anti-Oxidative Stress |
| Q35571070 | Purification, characterization, and biological activities of broccolini lectin |
| Q40190840 | Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy |
| Q92862205 | Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives |
| Q26766656 | Role of Helicobacter pylori infection in pathogenesis of gastric carcinoma |
| Q37324833 | Sequence Analysis of Hypothetical Proteins from Helicobacter pylori 26695 to Identify Potential Virulence Factors |
| Q92730109 | Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA |
| Q39165568 | Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes |
| Q95642199 | The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives |
| Q64112482 | The role of high sensitive C-reactive protein and histopathological evaluation in chronic gastritis patients with or without Helicobacter pylori infection |
| Q26852779 | Transforming growth factor-β: an important mediator in Helicobacter pylori-associated pathogenesis |
Search more.